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Hatem El-Shanti,16,17 Vinit B. Mahajan,18 Polly J. Ferguson,6 Jeffrey D. Axelrod,15 Anna-Elina Lehesjoki,19
Bernd Fritzsch,2 Diane C. Slusarski,2 John Wemmie,20,21 Naoto Ueno,1,22,* and Alexander G. Bassuk23,*
Epilepsy is heritable, yet few causative gene mutations have been identified, and thus far no human epilepsy gene mutations have been
found to produce seizures in invertebrates. Here we show that mutations in prickle genes are associated with seizures in humans, mice,
and flies.We identified human epilepsy patients with heterozygousmutations in either PRICKLE1 or PRICKLE2. In overexpression assays
in zebrafish, prickle mutations resulted in aberrant prickle function. A seizure phenotype was present in the Prickle1-null mutant mouse,
two Prickle1 point mutant (missense and nonsense) mice, and a Prickle2-null mutantmouse.Drosophilawith prickle mutations displayed
seizures that were responsive to anti-epileptic medication, and homozygous mutant embryos showed neuronal defects. These results
suggest that prickle mutations have caused seizures throughout evolution.Introduction
Epilepsy is a disabling and costly disease characterized by
recurrent seizures. Affecting approximately 1% of the popu-
lation, it requires long-term treatment and reduces produc-
tivity.1 For most patients, however, the underlying cause of
epilepsy remains unknown, impeding effective diagnosis
and treatment.1 Recently, a genemutation inhumanprickle
homolog 1 (Drosophila) (PRICKLE1 [MIM608500]) was asso-
ciatedwith an ataxia syndrome accompanied bymyoclonus
and seizures in patients with normal brain imaging and
normal intelligence,2 thus raising the possibility that muta-
tions in prickle genes might play a critical role in epilepsy.
However, the ability of prickle proteins to regulate seizures
has not yet been established. First discovered inDrosophila,3
prickle proteins are highly conserved throughout evolution.
CharacterizedbyPETandLIMdomains,4 theprickleproteins
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cell polarity (PCP).5 At the amino acid level, Drosophila
Prickle is 65% identical to human PRICKLE1 and 62% iden-
tical to PRICKLE2, and PRICKLE1 and PRICKLE2 are 59%
identical to each other (Deans et al.6 and poster abstract pre-
sented at the 14th International Conference on Genome
Informatics: Katoh, M., and Katoh, M. [2003]. Genome
Informatics 14, 587–588). Given the strong conservation
of prickle proteins throughout evolution, we hypothesized
that mutations in the prickle genes would lead to seizures
and epilepsy-related phenotypes in diverse species.Subjects and Methods
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Table 1. Prickle Mutations in Patients with Myoclonus Epilepsy
Patient # Mutation Nucleotide Amino Acid Change Sex Clinical Details
1 PRICKLE1 c.311G>A p.Arg104Gln both previously described mutation in familial
myoclonus-ataxia epilepsy patients2
2 PRICKLE1 c.431G>A p.Arg144His male myoclonic seizures, generalized EEG
pattern, mild mental retardation
3 PRICKLE1 c. 1414T>C p.Tyr472His female juvenile myoclonic epilepsy
4 PRICKLE2, c.[443G>A;
457G>A],
p.[Arg148His; Val153Ile] female myoclonic seizures, generalized EEG
pattern, ataxia.5 brother with same mutations
and similar clinical phenotype with myoclonic
seizures and generalized discharges
5 PRICKLE2 c.1813G>T p.Val605Phe male myoclonic seizures, generalized EEG pattern
6 PRICKLE2 deletion: chr3:62,
665,527 – 64,890,116
(hg18 coordinates).
deletion of gene male developmental delay, epilepsy, autisic disorder(IRB). Eighty-eight DNA samples from patients with myoclonus
epilepsy and 176 samples from ethnically matched controls
without myoclonus epilepsy were collected from either the NIH
Coriell Institute for Medical Research collection or from patients
phenotyped by an EEG showing generalized epileptiform
discharges, a physical exam, and history that included myoclonic
seizures. The history, physical exam, and EEG were performed by
C.G., T.B., R.P.S., E.B.-K., A.G.B., and H.E.-S. Patients who met
criteria included those with generalized tonic-clonic epilepsy,
juvenile myoclonic epilepsy, and myoclonic-astatic epilepsy.
Patients for whom a physical exam revealed any focal findings,
patients with focal epileptiform abnormalities, and patients who
experienced simple febrile seizures were excluded. All patients
gave informed consent according to local IRB-approved protocols.
Signature Genomic Laboratories is a CLIA-approved laboratory
conducting clinical microarray-based comparative-genomic
hybridization. A search of their laboratory database of cytogenetic
aberrations identified one epileptic patient (patient 6, Table 1)
with a deletion encompassing PRICKLE2 (MIM 608501).PRICKLE1 and PRICKLE2 Resequencing
Primers and conditions for PRICKLE1 (NM_153026.2) sequencing
including all exons and intron-exon boundaries were used as
previously described.1 Primers for PRICKLE2 (NM_198859.3)
sequencing (Table S1), including all exons and intron-exon
boundaries, were used at annealing temperature of 60.5C
(F ¼ forward primer, R ¼ reverse primer).Quantitative PCR
Primers were designed and ordered in accordance with the
TaqMan Gene Copy Number Assay protocol from Applied Biosys-
tems. Primers were designed within the exon boundaries of
PRICKLE1 and PRICKLE2.
Wemade serial dilutions from 100–3.125 ng from genomic DNA
of control samples to establish a standard curve for all of the
primers used in the assay. We compared primer efficiencies and
confirmed that primers passed all quality-control tests defined in
the 2DDCt method. In accordance with ABI protocol, endogenous
RNase Pwas used as a reference gene to be present in every reaction
so novel primers could be compared to a confirmed diploid gene.
TaqMan real-time PCR was carried out with 8 ng of dried gDNA
in a reaction volume of 5 ml, which was distributed as follows:The America2.5 ml 23 TaqMan universal PCR Master Mix, .25 ml VIC probe
RNaseP, .25 ml FAM probe custom-designed primers, and 2 ml
DNase and RNase free water.
An ABI 7900HT Fast Real-Time PCR system was used with the
2DDCt method for quantitative analysis. All samples were
analyzed in triplicate and compared to the RNaseP endogenous
control for a reference of diploid copy number. Irregular samples
were analyzed twice via the same protocol. Samples with DDCt
values < .7 were implicated as having possible deletions, and
samples withDDCt values> 1.3 were implicated as having possible
duplications.
Zebrafish
Adults were maintained in a 14 hr light/10 hr dark cycle at 28C.
Embryos were collected from natural pairwise matings and staged
by hours post-fertilization (hpf) at 28.5C. Morphological criteria
were described in Kimmel et al.7 Wild-type prickle2 was cloned
from a mixture of cDNAs for 0–24 hpf zebrafish embryos with
GeneAmpHigh Fidelity polymerase (Applied Biosystem). TheQuick
Change II site-directed mutagenesis kit (Stratagene) was used for
generating prickle2 point mutants encoding amino acids ortholo-
gous to the human double mutations p.[Arg148His;Val153Ile]
(p.[Arg144His;Val149Ile] (NM_183343.1:c.[431G>A;432A>T;445
G>A]) in zebrafish) and human p.Val605Phe (p.Leu596Phe
[NM_183343.1:c.(1786C>T;1788G>C] in zebrafish). To be clear
about which human mutations we are evaluating in the zebrafish
system,wewill refer to the zebrafish reagents that encode the ortho-
log of the human p.[Arg148His;Val153Ile] mutations as prickle2p.
Arg148His;Val153Ile. Likewise, we will refer to zebrafish reagents
that encode the ortholog of the human p.Val605Phe mutation as
prickle2Val605Phe. Synthetic RNAs were made with mMessage
mMachine Capped RNA transcription kit (Ambion). Equivalent
RNA amounts were injected into 1- to 8-cell-stage embryos (approx-
imately 6 nl of 100 ng/ml RNA). Myc-tagged forms of the wild-type
and mutant proteins all expressed stable protein of the same
mobility in cell culture (data not shown). Embryos were scored by
their morphology at both the 6–8 somite stage (SS) and 28 hpf. At
the6–8 SS, embryos that showedwider somites thanwild-typeunin-
jected embryos were scored as having a CE defect (data not shown).
At 28 hpf, embryos with a shorter A/P axis or with eye or forebrain
patterning defects were scored separately. Live embryos were photo-
graphed at 28 hpf after orienting in 3% methylcellulose. For statis-
tical analysis of morphological defects, embryos with CE defectsn Journal of Human Genetics 88, 138–149, February 11, 2011 139
and eyedefectswere considered altered.WeperformedFisher’s Exact
Test to compare mutants to uninjected embryos. p values smaller
than 0.05 were considered statistically significant.Intracellular Ca2þ Imaging
The ratiometric Ca2þ-sensing dye Fura-2 (Molecular Probes) was
injected into 1-cell zebrafish embryos. The excitation spectra are
different between Ca2þ-bound Fura-2 (340 nm) and Ca2þ-free
(380 nm) forms. By taking the ratio of the fluorescence intensity
at these wavelengths, one can derive an estimate of intracellular
free Ca2þ. prickle2 or prickle2 mutant RNA (75 ng/ml RNA) was
co-mixed with Fura-2, and 4–6 nl was injected into embryos.
Embryos were oriented in a lateral position in a glass-bottomed
dish on a Zeiss axiovert epifluorescence microscope. Image pairs
at 340 and 380 nm excitation wavelengths (510 nm emission)
were collected at 15 s intervals. Each imaging session collected
200 image pairs. The ratio image, a pixel-by-pixel match of both
excitation wavelengths, is calculated by computer software (Ratio-
Tool, Inovision). The sequence of ratio images was processed, and
the Ca2þ fluxes (transients) were determined with a subtractive
analog as described.8 The ratio image (340 nm, Ca2þ saturated;
and 380 nm, Ca2þ free) imported for publication was encoded in
8 bits and converted to pseudocolor ; a low ratio (low Ca2þ) is
represented by blue, and a high ratio (high Ca2þ) is represented
by yellow and red.In Situ Hybridization
An RNA probe against mouse prickle2 (nucleotides 1262–1891,
NM_001081146.2) was generated by in vitro transcription from
a plasmid containing prickle2 cDNA, and this probe was then
labeled with digoxigenin. Mice were fixed by perfusion with 4%
paraformaldehyde, and the brains were left to fix in the skull over-
night. After brains were dissected from the skull, they were split
sagittally and digested with 10 mg/ml Proteinase K (Ambion,
Austin, TX, USA) for 40 min. The half brains were hybridized over-
night at 60C in hybridization solutionwith 50% formamide, 50%
23 saline sodium citrate, and 6% dextran sulfate. Excess probe was
digested and washed off. Each half brain was then incubated over-
night with anti-digoxigenin antibody (1:2000, Roche diagnostics,
Mannheim, Germany) conjugated with alkaline phosphatase.
Nitroblue phosphate (BM purple substrate, Roche Diagnostics,
Germany) was used for probe detection. After reactions were
stopped, each half brain was washed, and images were taken
with a Leica M205 FA microscope and Leica Suite V3 software.Immunohistochemistry of Mouse Prickle2
Wild-type or mutant Prickle2 brain was harvested, fixed with 4%
PFA, and sectioned with a vibratome. Sections were 100 mm thick.
The sections were stained while they were floating. After staining,
they were placed on a slide and mounted. The staining conditions
were as follows: sections were washed with a Ca2þ- and Mg2þ-free
phosphate-buffered saline (PBS) and permeabilized with 0.5%
Triton X-100 PBS for 30 min at room temp. This was followed by
incubation with a blocking solution (0.25% Triton X-100, 2%
bovine serum albumin [BSA], and 13 PBS at pH 7) for 1 hr at
room temperature. They were then stained with primary Prickle2
rabbit antibody at a 1:500 dilution in blocking solution for 3–4 hr;
washed with 0.25% Triton X-100 PBS three times for 30 min at
room temp; and incubated with anti-rabbit secondary antibody
coupled to Alexa488 (Invitrogen) at a 1:500 dilution. Subse-
quently, the slices were again washed three times for 30 min in140 The American Journal of Human Genetics 88, 138–149, February0.25% Triton X-100 PBS. After these three washes, each slice was
washed overnight before being mounted in 0.25% Triton X-100
PBS at 4C. Mounting was done with Flouromount-G (Southern
Biotech).Production and Genotyping of Prickle1 and Prickle2
Mutant Mice
Prickle1 Riken Center for Developmental Biology accession number
CDB0431K;GenBank accessionnumberNM_001033217.4)mutant
mice were produced as described previously.9 The Prickle2 (acces-
sion number CDB0435K; NM_001081146.2) mutant mice were
generated via gene targeting in TT2 ES cells10,11 as described. We
analyzed Prickle1 and Prickle2 mutant mice produced from the
eighth backcross on C57BL/6. The genotyping of Prickle2 mutant
mice was routinely performed by PCR with a mixture of three
primers. The sizes of the PCR products were 796 bp for the wild-
type allele and 609 bp for the mutant allele. The PCR primers
were as follows: P1 (50-GAC CTC ATC TAC TTT TAC CAA-30) and
P3 (50-TAC TAC CAC CCA CTT TAT TCT-30) for the Prickle2 wild-
type allele; P2 (50-GGC TCT TTA CTA TTG CTT TAT-30) and P3 for
the Neo gene. The PCR conditions were 95C for 2 min, 35 cycles
of 95C for 10 s, 56C for 10 s, and 72C for 30 s, followed by
72C for 10 min.9–11
Mice with the p.Phe141Ser variant (Prickle1Phe141Ser) and mice
with the p.Cys251X variant (Prickle1Cys251X) mutant mice were
generated from an ENU-mutagenesis screen from Ingenium Phar-
maceuticals (Munich, Germany). The point mutant lines identi-
fied from the mutagenesis screen was backcrossed to C57/BL6
via a rapid congenic protocol12 (genome-wide microsatellite
markers used for genotyping are available upon request). Like
Prickle1-null mutants, no live homozygous Prickle1Cys251X were
identified in newborn pups, but Prickle1Cys251X heterozygotes
and wild-type pups were found in the expected numbers and
were used for maximal electroshock seizure threshold (MEST)
testing. Prickle1Phe141Ser live-born mice were found in all ex-
pected genotype combinations at birth, but there were insufficient
numbers of homozygous Prickle1Phe141Ser mice for MEST testing
at the time of submission.Pentylenetetrazol Evoked Seizures and
Electrocorticography (ECoG) Recordings
Three 3.2 mm stainless steel screws (Stoelting) were implanted
above the right frontal lobe, left parietal lobe, and right cere-
bellum. The first two electrodes were to serve as epidural recording
electrodes, and the latter were to serve as a reference or ground
electrode. The coordinates relative to the bregma were as follows.
Frontal: anterioposterior þ1.5 mm, lateral 1.5 mm. Parietal:
anteroposterior 3.0 mm, lateral þ1.5 mm. Cerebellar reference:
anteroposterior 6.0 mm. At least 3 days were allowed for mice
to recover prior to testing. Baseline ECoG activity was recorded
for 15 min prior to intraperitoneal injection of pentylenetetrazol
(PTZ; 50mg/kg). Recordings were continued for 75min after injec-
tion. ECoG activity was captured with a TDT MEDUSA preampli-
fier, and the base station and was recorded at a sampling rate of
2034.5 Hz with TDT OpenX software with high- and low-pass
filters at 1 Hz and 3000 Hz, respectively. ECoG recordings were
analyzed with MATLAB R2007b software. The threshold for spike
scoring was an excess of five times the standard deviation of the
mean preinjection baseline amplitude. The number of spikes was
statistically analyzed with a Student’s t test. Experimenters were
blinded to the mice genotypes during all steps, including PTZ11, 2011
testing and data analyses. All animal experiments complied with
the NIH Guide for the Care and Use of Laboratory Animals.Testing MEST
The electrical stimulus required to reach maximal electroconvul-
sive seizurewas determined as describedpreviously13 inPrickle2þ/,
Prickle2/, Prickle1þ/ , Prickle1þ/Cys251X, Prickle1þ/Phe141Ser,
and wild-type mice. The electroshock was given for 0.2 s at 60 Hz
with a maximal voltage of 500 V via the Rodent Shocker-type 221
(Harvard Apparatus, Holliston, MA) with ear electrodes moistened
with saline. Generalized seizure with hind-limb extension was
assessed. Fischer’s exact test was used for statistical analysis. All
mice were 10–14 weeks old. Wild-type mice (n ¼ 43) were C57/B6
littermates of prickle mutant mice tested at 7 mA and pooled into
one large group. Seizure rates between different sets of wild-type
mice were similar (data not shown). The following numbers of
mice were used for testing: The following numbers of mice were
tested: Prickle1þ/ (n ¼ 23), Prickle1Cys251X (n ¼ 5), Prickle1-
Phe141Ser (n ¼ 7), Prickle2þ/ (n ¼ 14), and Prickle2 / (n ¼ 7).
Seizure rates were also recorded for wild-type, Prickle1þ/,
Prickle2þ/, and Prickle2/ at 8 mA and 9 mA. There was no statis-
tical difference between genotypes at 8 mA and 9 mA, although
overall seizure rates increased (not shown).Drosophila Lines and Genetics
The pksple1/pksple1 flies were obtained from the Bloomington
Drosophila Stock Center housed at Indiana University. pksple1arose
spontaneously.3 Laboratory yw67 or Oregon-R (kindly provided by
Chun-Fang Wu) males were crossed with pksple1homozygous
mutant female flies to produce the pksple1/þ heterozygous flies;
these crosses produced flies whose background was either 50%
yw67 or 50% Oregon-R. Both the control flies and pksple1 heterozy-
gotes were subjected to identical culture conditions and standard
Drosophila cornmeal food media.Immunocytochemistry of Fly Brains and Embryos
Crawling third-instar larvae from the laboratory strain yw67 were
bisected, and the interior halveswere inverted in PBS. After fixation
in 4% formaldehyde in PBS for 30 min, the carcasses were washed
five times for 10min in PBST (PBS and 0.1% Triton X-100), blocked
with PBSTB (PBST and 1% BSA) for 40 min, and incubated with
a 1:2000 dilution of rabbit polyclonal antibody raised against
Drosophila prickle (provided by Jeff Axelrod) overnight at 4 centi-
grade. The carcasses were washed five times for 10 min in PBST,
blocked with PBSTB for 40 min, and incubated with a fluorphore-
conjugated secondary antibody (Alexa Fluor 488 goat anti-rabbit
IgG (HþL); Invitrogen catalog number A-11008) for 90 min at
room temperature. The carcasses were washed five times for
10 min with PBST, and the brains were dissected from the carcasses
andmounted inVectashield containingDAPI (Vector Laboratories).
Images were obtained with a Leica TCS SPE confocal microscope.
Peripheral nervous system neurons were visualized in 14- to
16-hr-old yw67 or pksple1 homozygous mutants via a 22C10
primary antibody (1:200 dilution of antibody concentrate, Devel-
opmental Studies Hybridoma Bank, University of Iowa, Depart-
ment of Biology) followed by an Alexa Fluor 488 goat anti-mouse
IgG (HþL) (Invitrogen catalog number A-11001) secondary
antibody. Embryo fixation and antibody incubations were per-
formed as previously described,14 and images were obtained via
fluorescence microscopy.The AmericaModified Bang-Sensitivity Behavioral Assay
The ‘‘bang-sensitivity’’ behavioral assay measuring recovery from
epileptic seizures was performed as previously described with
slight variation15–17. Twenty flies (ten females and ten males)
aged up to 7 days after eclosion were collected under C02 and
transferred to an empty glass vial demarcated with centimeter
markers up to 7 cm. Vials with either control or mutant flies
were mechanically stimulated by insertion into a Fisher Scientific
vortex mixer set to ‘‘10’’ (highest setting). The flies were first pre-
vortexed for 20 s to ensure that all flies were able to survive the
assay and climb after vortexing (control and mutant flies were
age matched and vortexed simultaneously). Two minutes later,
flies were simultaneously vortexed for 20 s and then placed on
a flat lab bench. Flies were digitally videotaped with a Panasonic
SDR-S7 camera. Digital video was then reviewed frame by frame
at 5 s intervals up to 25 s. As previously defined, flies were scored
as ‘‘recovered’’ when they climbed to the top of the vial (7 cm). In
addition to the climbing assay, we scored flies for recovery ‘‘off
bottom’’ if they were able to recover from seizure activity, begin
coordinated locomotive behavior, and leave the bottom of the
vial. All scoring was statistically analyzed with Chi-Square
analysis.
Valproic Acid Treatment of Drosophila
Either no valproic acid or 10 mM valproic acid (Sigma; final
concentration) was added to standard cornmeal-based fly food,
and 1- to 7- day-old flies were allowed to consume the agar for
84 hr, after which the bang-sensitivity assay was performed imme-
diately. This dosage of valproic acid was lethal in homozygous
pksple1 flies, and only heterozygotes were used for this testing.
Statistical Methods
For statistical evaluation of association between missense variants
in prickle genes and myoclonus epilepsy, we used Fisher’s two-
tailed exact test. Missense variation or no missense variation are
the possible categorical outcomes for each chromosome. Affected
and normal (ethnically matched controls) are the two groups. For
the affected group, 5/176 chromosomes were missense, and for
the control group, 0/352 chromosomes were missense.
For statistical evaluation of neurodevelopmental anomalies in
pksple1/pksple1 versus yw67 control flies, we used Fisher’s two-tailed
exact test and neurodevelopmental anomaly versus no neurodeve-
lopmental anomaly as the possible categorical outcomes for these
two groups of flies. For pksple1/ pksple1, 11/230 presented with neu-
rodevelopmental anomalies; for yw67 controls, 0/399 were anom-
alous.
MEST and the bang-sensitivity assay were evaluated by Chi-
Square analysis. PTZ testing was evaluated with the Student’s t
test. The zebrafish development assay was analyzed with the
Fisher’s exact test. n values for all experiments are included in
the figure legends.Results
Heterozygous Mutations in PRICKLE1 or PRICKLE2
in Epilepsy Patients
Our original report of a human PRICKLE1 mutation
described a homozygous mutation in PRICKLE1 in families
with myoclonus epilepsy-ataxia syndrome.2 However, the
role of aberrant PRICKLE1 and the closely relatedn Journal of Human Genetics 88, 138–149, February 11, 2011 141
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Figure 1. Zebrafish Prickle Mutations Orthologous to Those
Identified in Human Epilepsy Patients Show Altered Activity in
CE and Calcium Release
(A–D) Morphological phenotypes at 28 hpf. Compared to wild-
type uninjected embryos (A), prickle2-injected embryos (B) display
a shorter A-P axis and a kinky tail. The lateral view is shown, and
anterior is to the left. Moreover, prickle2-injected embryos (D)
show defects in eye and forebrain patterning at 28 hpf. (C) Unin-
jected embryo. Ventral view. The numbers of embryos with defects
in each RNA-injected group are shown in Table 2.
(E–H) Surface plots of calcium release activity were generated from
images of live zebrafish embryos. The height and color of the peaks
indicates the number of calcium fluxes observed over the course of
the experiment; the embryos are oriented in a lateral position. (E)
A control injected embryo. (F) An embryo overexpressing wild-
type prickle2 RNA. (G) An embryo overexpressing prickle2Val605-
Phe-mutant-encoding RNA. (H) An embryo overexpressing prickle2
Arg148His; Val153Ile-mutant-encoding RNA.PRICKLE2 in the general population of patients with
myoclonus epilepsy has not been examined. To test
whether mutations in prickle genes are associated with
epilepsy, we sequenced PRICKLE1 and PRICKLE2 in 88
unrelated patients with myoclonus epilepsy. We found
two patients with missense mutations in PRICKLE1 and
two patients with missense mutations in PRICKLE2
(Table 1, patients 2–5).18 In addition, we identified
a patient with epilepsy and an interstitial chromosomal
deletion encompassing PRICKLE2. (Table 1, patient 6). All
four patients with missense changes were heterozygous
for the variants and had neither deletions nor duplications
in PRICKLE1 or PRICKLE2 exons. We did not identify the
variants observed in our patients in any of the 2100 Centre
d’Etudes du Polymorphisme Humain Human Genome
Diversity (CEPH-HGD) control chromosomes we screened,
none of the variants are reported in the 1000 genomes
database or in dbSNP, and we found no novel variants or
deletions in the PRICKLE1 and PRICKLE2 genes in 352
ethnically matched control chromosomes (two-tailed
Fisher’s exact test, p value for association ¼ 0.004; see
statistical methods). (An additional patient with
a PRICKLE2 deletion and one with a PRICKLE1 deletion
were also identified by Signature Genomics [not shown].
They are known to have neurological phenotypes, but
epilepsy was not reported at the time of testing, and addi-
tional information could not be gathered). No patients
with PRICKLE1 or PRICKLE2 exon-encompassing deletions
have been reported in the SickKids Foundation Database of
Genomic Variants the Children’s Hospital of Philadelphia,
the Database of Genomic Variants Archive (DGVa) at the
European Bioinformatics Institute, or the Database of
Genomic Structural Variation (dbVar) at the National
Center for Biotechnology Information. These results
suggest that the heterozygous variants we observed in
the prickle genes are associated with myoclonus epilepsy.
Mutant Prickle2 Shows Decreased Activity
in Zebrafish Overexpression Assays
Misregulation of WNT/PCP has been shown to disrupt
convergent-extension (C-E) movements during gastrula-
tion in vertebrates19.We have previously demonstrated
that overexpression of mutant PRICKLE1 identified in
epilepsy patients has a decreased ability to produce C-E
defects in developing zebrafish embryos.2 To investigate
whether mutant PRICKLE2 variants identified in epilepsy
patients are functionally different from the wild-type
in vivo, we injected RNA encoding either the wild-type
or mutant prickle2 RNAs (for whichmutations in the zebra-
fish were orthologous to those found in epilepsy patients 4
and 5; Table 1) into zebrafish embryos. Overexpression of
wild-type Prickle2 alters C-E movements in gastrulation,
resulting both in a reduced anterior-posterior length in
comparison to that of uninjected embryos (Figures 1A
and 1B) and in forebrain and eye defects (Figures 1C and
1D). Embryos expressing prickle2 mutant RNA showed
a significantly different phenotype than did those express-142 The American Journal of Human Genetics 88, 138–149, Februarying wild-type prickle2. The p.[Arg148His;Val153Ile] prickle2
ortholog showed increased activity compared to wild-type
activity, and the p.Val605Phe prickle2 ortholog showed
decreased activity compared to wild-type activity (Table
2). Thus, in an overexpression assay, the identified human
PRICKLE2 mutations show altered activity in zebrafish.prickle2 Mutations Result in Reduced Calcium
Activation in Zebrafish
We next sought to evaluate the in vivo physiological
consequences of identified human PRICKLE2 mutations.
Overexpression of zebrafish prickle1 in the developing
embryo is sufficient to activate calcium release frequency.5
We therefore evaluated the impact of wild-type and
mutant prickle2 on calcium release dynamics in vivo.
Embryos injected with the calcium sensor Fura-2 and
expressing wild-type or mutant prickle RNAs were imaged11, 2011
Table 2. Summary of Overexpression Phenotypes in Zebrafish Embryos
CE Defects CEþ Eye Defects Normal
p Value, Compared
to prickle2 Wild-Type
Uninjected (n ¼ 58) 0 0 100% <0.01
prickle2 wild-type (n ¼ 139) 79% 34.5% 20.1%
prickle2Arg148His;Val153Ile (n ¼ 205) 88.3% 28.3% 11.7% 0.045
prickle2Val605Phe
(n ¼ 148)
66.2% 34.5% 33.8% 0.012continuously at 15 s intervals during early epiboly stages
(Figures 1E–1H). We used a subtractive algorithm to eval-
uate calcium release dynamics,5 and changes are repre-
sented as a color-scale surface plot showing the number
of events relative to the location in the embryo for the
duration of the time course. In uninjected embryos, we
observed a characteristic frequency of endogenous calcium
release (Figure 1E, Movie S1). Expression of wild-type
prickle2 RNA in zebrafish embryos was sufficient to activate
calcium release (Figure 1F, Movie S2). Embryos expressing
either prickle2Val605Phe (Figure 1G and Movie S3) or
prickle2Arg148His;Val153Ile (Figure 1H and Movie S4)
were less active in stimulating calcium release than those
expressing wild-type prickle2 RNA. These results suggest
that the missense PRICKLE2 mutations identified in
epilepsy patients alter the in vivo physiological activity
of Prickle2 in zebrafish.Decreased Seizure Threshold in Mouse Models
Deficient for the Prickle Genes
To directly test whether heterozygous mutations in prickle
genes might cause epilepsy, we evaluated seizure threshold
in the following mutant mouse lines: (1) Prickle1þ/, (2)
Prickle1 Cys251X, which has a mutation encoding
a nonsense amino acid change that truncates the Prickle1
protein shortly after the PET and LIM domains, (3) Prickle1
Phe141Ser heterozygous mutant mice, which have a muta-
tion encoding a Phe141Ser amino acid change that alters
an amino acid in the PET/LIM domain that is conserved
throughout evolution, and (4) in mice heterozygous for
null mutations in Prickle2 . Seizure threshold was tested
via the maximal electroconvulsive seizure threshold
(MEST) test, which scores the occurrence of tonic hind-
limb seizures at a specific amperage of applied electrical
shock. Prickle1þ/, Prickle1þ/Cys251X, Prickle1þ/Phe141Ser,
and Prickle2 heterozygous (Figure 2A) mice all displayed
a decreased seizure threshold compared to that of wild-
type littermates. These results demonstrate that heterozy-
gous null or point mutations in the prickle genes are
sufficient to lower seizure threshold. Moreover, the seizure
predisposition in the Prickle1þ/Phe141Ser mice suggests
that disruption of the highly conserved PET/LIM domain
is sufficient to lower seizure threshold.
Althoughwe observed no live-born Prickle1 homozygous
knockout mice9 or Prickle1Cys251X/Cys251X mice
(see Subjects and Methods), we found viable Prickle2/The Americamice at expected Mendelian ratios (Figures S1 and S2.
Prickle1Phe141Ser/Phe141Ser mice were born at apparently
normal Mendelian ratios and appear normal, but there
were insufficient numbers at the time of submission to
test for seizures). As we previously showed for Prickle1,2
Prickle2 is expressed in epilepsy-associated brain regions,
including the hippocampus and cerebral cortex
(Figure S3), and expression was lost in Prickle2-null mice
(Figures S2C and S2D). Prickle2/ mice displayed higher
seizure rates than Prickle2þ/ mice (Figure 2A). We also
observed increased epileptiform discharges in Prickle2/
mice compared to controls after treatment with the
seizure-inducing GABA agonist pentylenetetrazole (PTZ)
(Figures 2B–2E). These data suggest that Prickle2 dosage is
directly related to seizure threshold.Drosophila with Homozygous prickle Mutations
Display Seizures
To test whether a pricklemutation would lead to seizures in
Drosophila, we obtained homozygous pricklespiny-leg-1
(pksple1) mutant flies; this mutation was described more
than 60 years ago as a recessive loss-of-function allele
showing typical planar cell polarity abnormalities,
including anomalies in the body epidermis and legs (and
including duplications of leg tarsal joints).4,20 Despite
diffuse localization of Prickle in the developing fly brain
(Figure 3), neurological phenotypes have not been
described for any mutant line deficient for the prickle
genes. To formally test whether prickle mutations in flies
lead to an epilepsy-like disorder, we subjected pksple1 homo-
zygous mutants to a variation of the classic ‘‘bang sensi-
tivity’’ assay.16,21 In thismodel for seizure sensitivity, a glass
vial containing flies is vortexed, inducing seizures in flies
genetically predisposed to this disorder (such flies demon-
strate dramatic twitching behavior similar to seizures
observed in mice and humans [Figure 4A], and electro-
graphic recordings have substantiated these findings).16,21
The seizures prevent or delay flies from climbing the vial
wall, which is the normal behavior of wild-type flies.
Homozygous pksple1mutant flies displayed a severely de-
layed recovery resulting in a prolonged climbing response
compared to that of yw67control flies (Figures 4B and 4C;
see also Movie S5), even though the homozygous pksple1
flies climb in a manner similar to control flies both before
and minutes after bang testing (Movies S6 and S7, respec-
tively).n Journal of Human Genetics 88, 138–149, February 11, 2011 143
Raw ECoG trace for Prickle2 -/- mouse
Raw ECoG trace for Prickle2 +/+ mouse




































































































Figure 2. Mouse Models Deficient for
the Prickle Genes Show an Increased
Seizure Phenotype
(A) Maximal electroshock seizure
threshold (MEST) in wild-type mice versus
mice deficient for the prickle genes.
Prickle1þ/, Prickle1þ/Cys251X, Prickle1þ/
Phe141Ser, Prickle2þ/, and Prickle2/
mice show a significantly lower MEST
than wild-type mice at 7 mA (*p < 0.001,
**p < 0.005; wild-type n ¼ 43, Prickle1þ/
n ¼ 23, Prickle1þ/Cys251X n ¼ 10,
Prickle1þ/Phe141Ser n ¼ 12, Prickle2þ/
n ¼ 14, and Prickle2/ n ¼ 7).
(B and C) Total number of electrographic
spikes recorded from electrocorticography
(ECoG) in response to pentylenetetrazol
(PTZ) injection for the first 50 min after
injection (B) and the last 25 min of
recording after injection (C). During the
first 50 min after injection, there is no
difference in the total number of spikes
between wild-type and Prickle2/ mice.
However, there is a significant difference
seen during the last 25 min of recording:
Prickle2/ mice had significantly more
seizures than their wild-type counterparts.
*p ¼ 0.039 as determined by the Student’s
t test; wild-type n ¼ 7, Prickle2/ n ¼ 6.
Error bars represent SEM.
(D and E) Representative ECoG traces for
wild-type and Prickle2/ mice upon stim-
ulation with PTZ. PTZ was injected (black
arrow) after 15 min of baseline recording.
ECoG was recorded for 75 min after injec-
tion. A wild-type raw trace recording is
shown in (D). A Prickle2/ raw trace
recording is shown in (E). In comparison
to wild-type mice, Prickle2/ mice
continue to seize for prolonged periods
after injection.Heterozygous prickle Mutations Cause Seizures
in Drosophila
To test whether the heterozygous prickle mutation was
sufficient to decrease seizure threshold, we tested pksple1
heterozygotes (which we produced by crossing pksple1
homozygous mutants with yw67 control flies) for bang
sensitivity. We found that pksple1 heterozygotes displayed
none of the morphological abnormalities found in the
homozygotes, such as tarsal duplications or altered bristle
polarity (data not shown), yet the pksple1 heterozygotes
were significantly more bang sensitive than control flies
of the same age (Figure 4B and Movie S8). In addition to
using the classic bang-sensitivity parameters, we also
scored the time it took for the flies to leave the bottom of
the vial. Again, pksple1 heterozygotes were significantly
impaired compared to controls (Figure 4C) and displayed
an agitated recovery period in which they visibly exhibited
excessive excitability in the form of grooming themselves144 The American Journal of Human Genetics 88, 138–149, Februarymore than usual and flipping over on their backs and
then righting themselves (Figure 4A and Movie S9).
To test whether anti-epileptic drugs reverse the bang
sensitivity, we used valproic acid (VPA), an anti-epileptic
medication used for treatment of myoclonus epilepsy in
humans (including humans with PRICKLE1 mutations2)
and shown to decrease seizure activity in other bang-sensi-
tive flies.22 VPA strongly decreased bang sensitivity in
pksple1 heterozygotes, whose climbing behavior resembled
that of the control fly group (Figures 4D and 4E).
In order to test whether the prickle epilepsy phenotype
could be observed in two different genetic backgrounds
(which would reduce the likelihood that a particular
genetic background had a role in the phenotype), we
crossed the pksple1 homozygotes to a second laboratory
strain, Oregon-R. Both the Oregon-R and yw67 flies are
standard ‘‘workhorse’’ laboratory strains that have been
utilized for many years. The Oregon-R strain is derived11, 2011
A B
C D
Figure 3. Prickle Is Expressed Widely in the Drosophila CNS
A Prickle-specific polyclonal antibody was used for visualization of
Prickle in the crawling third-instar larval CNS.Most neurons of the
larval CNS persist through metamorphosis and join groups of
newly born adult-specific neurons to form the adult CNS.
(A) Prickle is localized in the optic lobes (one lobe is indicated by
the red arrow), as well as central brain structures between the
lobes, and to part of the ventral segmental ganglia (white arrow).
High-level staining is not seen in ventral segmental ganglia that
correspond to the abdominal segments (yellow arrow).
(B) A higher magnification of the optic lobe region of the brain
shows Prickle staining in clusters of bundled neurons (white
arrow) as well as neuronal projections spanning the optic lobe
(yellow arrow).
(C) A higher magnification of the ventral segmental ganglia shows
Prickle staining in the commisures that cross the ganglia (yellow
arrow) as well as in clusters of neurons similar to those seen in
the optic lobe regions of the brain (white arrow).
(D) A higher magnification of the surface of the ventral segmental
ganglia shows Prickle staining in clusters of neurons (white arrow);
note that the ventral segmental ganglia corresponding to the
abdominal segments is largely devoid of high Prickle staining
(yellow arrow).from wild flies that were collected in 1925 or earlier by DE
Lancefield at Roseburg, Oregon.23 The yw67 flies have a less
clear origin and contain two mutations (in the yellow and
white genes) useful in molecular genetic manipulations,
such as P-element-mediated transformation. These muta-
tions affect body and eye color, respectively. yw67 is one
of the most common laboratory strains utilized by
Drosophila researchers worldwide because of its ease of
culture and usefulness in transformation. The w67 muta-
tion was generated by Lefevre, probably in a Canton S
background because this was the wild-type strain he often
used for his mutagenic studies on the white gene.24 None-
theless, because of their different genotypic backgrounds,
yw67 and Oregon-R have been cultured separately for
many years and thus can be appropriately considered to
be separate fly strains25,26. We compared pksple1/þ (Ore-
gon-R) heterozygous flies to the wild-type Oregon-R flies.
As in the yw67 background, pksple1 heterozygous flies in
the Oregon-R background showed increased seizures in
a comparison with controls (Figures 4F and 4G).The AmericaHomozygous pksple1 Mutant Embryos Display
Neuronal Defects
Inorder todeterminewhetheradevelopmentally controlled
neuronal defect might be causative for the epilepsy pheno-
type inflies,we stained pksple1homozygousmutant embryos
with the 22C10 antibody, widely used to stain neurons of
the peripheral nervous system (PNS). Because we had
observed a decreased viability of pksple1homozygousmutant
flies (datanot shown),wespecifically looked for grossdefects
in the architecture of the developing nervous system
(Figure 5). We focused on obvious defects represented by
altered patterns of 22C10 staining that were present in fully
intact embryos showing no damage from the antibody
staining and mounting procedure. Thus, we identified 11
out of 230 pricklemutant embryos that showed suchdefects,
whereas 0 out of 399 control embryos showed such defects
(two-tailed Fisher’s exact test, p value ¼ 0.0001). One
striking feature of the mutant embryos was a generalized
disorganization of the PNS: aberrant migration of neuronal
processes resulted in improper connections. For example,
Figure 5B shows a mutant embryo whereby two neuronal
processes associated with contiguous chordotonal organs
have improperly fused.Discussion
Most generalized epilepsy-causing mutations have been
identified in genes that encode ion channels.1,27–31 The
work presented here is atypical in that it affects a non-
ion-channel protein. The original descriptions of non-
ion-channel-generalized epilepsy-associated mutations
showed autosomal-recessive inheritance,32–34 with the
exception of EF-HAND DOMAIN (C-TERMINAL)-CON-
TAINING PROTEIN 1 (EFHC1, [MIM 608815]) mutants,
which are autosomal dominant.35,36 However, both hu-
mans and mice heterozygous for mutations in the myoc-
lonus epilepsy gene CYSTATIN B (CSTB, [MIM 601145])
have been reported to display EEG and clinical abnormal-
ities37–39 (also see Table S2). Similarly, in the case of
PRICKLE1, both heterozygous and homozygous genotypes
can be associated with myoclonus epilepsy in humans.
Finally, the finding that both heterozygous and homozy-
gous mutations in both vertebrates and invertebrates can
lead to epilepsy suggests that the dosage of the various
prickle proteins is critical in carrying out their normal
functions.
The precise mechanism for how seizures are produced
remains amystery. This work implicates prickle-dependent
signaling in seizure prevention. It is not yet certain how
abnormal prickle proteins cause epilepsy, but we envision
two possible mechanisms. First, during vertebrate embryo-
genesis, prickle proteins and other planar cell polarity
(PCP) core components have been shown to control the
formation of multiple structures through the regulation
of cell polarity,6,8,40–52 suggesting that during neurogene-
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Figure 4. Drosophila that are Homozygous or
Heterozygous for the prickle mutation pksple1Are
Predisposed to Seizures, and Seizures are
Diminished by Treatment with Valproic Acid
(A) Seizure in a pksple1 fly. Photos of typical homo-
zygous pksple1-seizing fly were captured every
0.5 s after the bang assay. All control flies have
already climbed up the side of the vial for the
time period presented. For a live side-by-side
comparison of control and pksple1 flies, seeMovies
S5–S9.
(B) pksple1 homozygous flies and pksple1 heterozy-
gous flies in the yw67 (yw) background [pksple1/þ
(yw)] have significantly impaired seizure
recovery when they are compared to same-aged
control yw67 [þ/þ(yw)] flies. *p < 0.001,
**p ¼ 0.039.
(C) pksple1 homozygous and heterozygous flies
have significantly impaired recovery off the
bottom in comparison to same-aged control
þ/þ(yw) flies. *p < 0.001, **p ¼ 0.001.
(D) The addition of valproic acid to fly food
significantly diminishes seizures in pksple1 hetero-
zygotes [pksple1/þ (yw)] and returns climbing
ability to that of control þ/þ(yw) flies.
*p < 0.001, **p ¼ 0.002, ***p ¼ 0.001.
(E) The addition of valproic acid to fly food signif-
icantly recovers the ability of the flies to right
themselves off the bottom of the vial and climb.
*p ¼ 0.002, **p ¼ 0.010, ***p ¼ 0.001,
****p ¼ 0.005.
(F and G) pksple1 heterozygous flies are bang sensi-
tive in multiple backgrounds. (F) pksple1 heterozy-
gous flies in the Oregon-R (OR) background
[sple1/þ(OR)] have significantly impaired seizure
recovery in comparison to same-aged wild-type
Oregon-R [þ/þ (OR)] flies. *p ¼ 0.007. (G)
sple1/þ(OR) heterozygous flies have significantly
impaired recovery off bottom in comparison to
same-aged wild-type þ/þ(OR) flies. *p ¼ 0.007.
For all experiments, wild-type n ¼ 60 and pksple1
n ¼ 60. Error bars represent standard error of
the mean; the data were statistically analyzed
with the Chi-square test.functional neural network, by directing neural migration
(or the migration of neuronal processes such as axons
and dendrites) via a polarized plane, by polarizing a neuron
that has properly migrated to its final position (either
through shuttling cellular components to particular loca-
tions along a directional axis or by positioning the location
of neuronal structures such as axons and dendrites), or
a combination of both. This possibility is supported by
the findings that prickle1b knockdown disrupts motor
neuron migration in zebrafish,51 Prickle knockdown
disrupts neurite extension in vitro,53 and social interaction
is abnormal in mice with mutations in the PCP gene
Dvl154. Our results demonstrating migration defects of
neurons or neuronal processes in pksple1 homozygous
mutant fly embryos are consistent with these developmen-
tally based mechanisms and suggest that a defect specifi-
cally affecting neuronal positioning could be the root
cause of epilepsy in prickle mutants.146 The American Journal of Human Genetics 88, 138–149, FebruarySecond, the altered calcium signaling in prickle mutants
combined with decreased seizure activity in the presence
of valproic acid (an anti-epileptic medication that has
several effects on calcium signaling, including interference
with inositol and alteration of calcium currents2,55,56)
suggests that prickle-mediated calcium signaling might
underlie prickle function in the nervous system and that
prickle-mediated epilepsy is related to dysregulated
calcium currents. In both cases, the cellular pathology of
defective neurons may be attributable to the disruption
of polarized trafficking of membrane and functional
proteins, including channels that are required for proper
regulation of neural activities and neuron networking,
highlighting the essential role of PCP core components
in neurogenesis and in the regulation of brain function.57
An epilepsy phenotype that is found in disparate species
and crosses the invertebrate-vertebrate transition strongly







A CB Figure 5. Neuronal Defects Are Observed in
prickle Mutant Embryos
Images (203) of control 14–16 hr yw67 embryos
(A) are compared to two 14–16 hr pksple1homozy-
gous mutant embryos (B and C) that have been
stained with the 22C10 antibody so that PNS
neurons are visualized. Note the location of
chordotonal organs (asterisks in A) as well as the
location of the ventral nerve chord (upward
arrow in A) in the control embryo. For themutant
embryo in (B), note the aberrant neuronal
processes that have joined (arrow) as well as the
abnormal location of two chordotonal organs (asterisks). For the mutant embryo in (C), note the overall disorganized PNS staining
pattern, as well as the improperly positioned neurons associated with the chordotonal organ in abdominal segment 6 (asterisk). Anterior
is to the left, and ventral is down but slightly rotated toward the viewer.conserved evolutionary pathway for regulating seizures.
Drosophila provide a powerful genetic tool for dissecting
the key elements of this seizure pathway in the form of
suppressor and enhancer screens. Furthermore, given the
ease with which compounds can be added to fly food,
and the ability to rapidly screen for seizure activity, we
foresee that the results presented here will promote the
efficient translation of prickle-related epilepsy into novel
treatments.Supplemental Data
Supplemental Data include three figures, two tables, and nine
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